Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis.
We report a 3-year-old girl with hemophagocytic lymphohistiocytosis (HLH) who received BMT from an HLA-identical unrelated donor when the disease was active. She had entered remission in response to chemotherapy consisting of etoposide and methylprednisolone. After a relapse, her disease became refractory to chemotherapy, and splenectomy was performed with marginal improvement. She underwent BMT from an HLA-identical unrelated donor, conditioned with CY, TBI and anti-thymocyte globulin (ATG). She has been in complete remission for 18 months since the BMT. This result suggests that BMT from an HLA-identical unrelated donor should be considered for HLH even if the disease is active.
Adachi
S
S
Department of Pediatrics, Kyoto University, Japan.
Kubota
M
M
Akiyama
Y
Y
Kato
T
T
Kitoh
T
T
Furusho
K
K
D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D005260:Female; D006680:HLA Antigens; D015616:Histiocytosis, Non-Langerhans-Cell / Q000628:therapy*; D006650:Histocompatibility Testing; D006801:Humans; D014184:Transplantation, Homologous
D006680:HLA Antigens